Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment

Diabetes

Volumn 51, Issue 6, 2002, Pages 1913-1920

  Sreekumar, Raghavakaimal ^a   Halvatsiotis, Panagiotis ^a   Schimke, Jill Coenen ^a   Sreekumaran Nair, K ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLIPIZIDE; GLUCOSE; INSULIN; MESSENGER RNA; METFORMIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN TREATMENT; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE;

EID: 0036266251     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.6.1913     Document Type: Article

References (51)

1. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections
2. Type 2 diabetes among the Prima Indians of Arizona: An epidemic attributable to environmental change?
3. Pathophysiology of insulin resistance in human disease
4. Insulin resistance is central to the burden of diabetes
5. Candidate genes for insulin resistance
6. Insulin resistance in relatives of NIDDM patients: The role of physical fitness and muscle metabolism
7. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents
8. Cellular mechanisms of insulin resistance
9. Insights into insulin resistance and type 2 diabetes from knockout mouse models
10. Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM
11. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin dependent (type II) diabetes independent of impaired glucose uptake
12. Uncoupling protein 3 is reduced in skeletal muscle of NIDDM patients
13. Molecular scanning of the insulin-responsive glucose transporter (GLUT4) gene in NIDDM subjects
14. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM
15. Insulin resistance differentially affects the PI 3-kinase and MAP kinase mediated signaling in human muscle
16. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects
17. Rad: A member of the Ras family overexpressed in muscle of type II diabetic humans
18. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
19. Calpain-10: The first positional cloning of a gene for type 2 diabetes?
20. Expression monitoring by hybridization to high-density oligonucleotide arrays
21. Minimal modeling, partition analysis, and the estimation of insulin sensitivity
22. Practical closed-loop insulin delivery: A system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics
23. Leucine incorporation into mixed skeletal muscle protein in humans
24. Light-directed, spatially addressable parallel chemical synthesis
25. A high-density probe array sample preparation method using 10- to 100 fold fewer cells
26. Age effect on transcript levels and synthesis rate of muscle MHC and response to resistance exercise
27. Senescence-related changes in gene expression in muscle: Similarities and differences between mice and men
28. Differential global gene expression in red and white skeletal muscle
29. Gene expression profile of aging and its retardation by caloric restriction
30. Enhanced secretion of insulin plays a role in the development of atherosclerosis and restenosis of coronary arteries: Elective percutaneous transluminal coronary angioplasty in patients with effort angina
31. The additive effects of glucose and insulin on the proliferation of infragenicular vascular smooth muscle cells
32. Atherosclerosis seems not to be associated with hyperinsulinaemia in patients with familial hypercholesterolaemia
33. Contribution of fasting hyperinsulinemia to prediction of atherosclerotic cardiovascular disease status in 293 hyperlipidemic patients
34. Coronary heart disease-a free radical associated disease? What is the value of antioxidant substances?
35. Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes
36. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase
37. Mitochondrial Mitochondhal disease in superoxide dismutase 2 mutant mice
38. Obesity and hyperleptinemia in metallothionein (-I and -II) null mice
39. Over expression of Rad inhibits glucose uptake in cultured muscle and fat cells
40. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM
41. Regulatory and cytoskeletal proteins of vertebrate skeletal muscle
42. Physiological implications of the presence, distribution, and regulation of calmodulin in eukaryotic cells
43. Activation of smooth muscle contraction: Relation between myosin phosphorylation and stiffness
44. Insulin resistance and cardiovascular disease
45. Obesity and insulin resistance
46. Muscle fiber composition and capillary density in women and men with NIDDM
47. Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus
48. Insulin action on metabolism
49. Variant sequence of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus
50. Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients
51. Circulating levels of free insulin-like growth factors in obese subjects: The impact of type 2 diabetes